Bacterial vaginosis and vulvovaginal candidiasis: optimal treatment regimens for patients with mixed infection

Kuznetsova I.V.

doi:https://doi.org/

References:

Atroshkina M.E., Il'ina E.N., Plakhova K.I. Razrabotka DNK-biochipa dlya issledovaniya mikrobnykh soobshchestv. Mol med 2009; 3: 23-31.
Metodicheskie materialy po diagnostike i lecheniyu naibolee rasprostranennykh infektsii, peredavaemykh polovym putem i zabolevanii kozhi. Pod red. A.A. Kubanovoi. M: GEOTAR-Media 2003; 448.
Plakhova K.I., Gomberg M.A., Atroshkina M.E., Il'ina E.N., Govorun V.M. Rol' Atopobium vaginae pri retsidivirovanii bakterial'nogo vaginoza. Vestn dermatol i venerol 2007; 5: 9-13.
Allsworth J.E., Peipert J.F. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007; 109: 1: 114-120.
Anderson M.R., Klink K., Cohrssen A. Evaluation of vaginal complaints. JAMA 2004; 291: 1368-1379.
Antonio M.A., Meyn L.A., Murray P.J., Austin M.N., Beigi R.H. Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. J Infect Dis 2009; 199: 1506-1513.
Beigi R.H., Austin M.N., Meyn L.A., Krohn M.A., Hillier S.L. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004; 191: 1124-1129.
Beigi R.H., Meyn L.A., Moore D.M., Murray P.J., Antonio M.A. Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol 2004; 104: 926-930.
Bradshaw C.S., Morton A.N., Hocking J., Tabrizi S.N., Fairley C.K. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193: 11: 1478-1486.
Bradshaw C.S., Tabrizi S.N., Fairley C.K., Morton A.N., Hocking J. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis 2006; 194: 6: 828-836.
Burton J.P., Chilcott C.N., Al-Qumber M., Brooks H.J., Wilson D., Tagg J.R., Devenish C. A preliminary survey of Atopobium vaginae in women attending the Dunedin gynaecology out-patients clinic: Is the contribution of the hard-to-culture microbiota overlooked in gynaecological disorders? Aust N Z J Obstet Gynaecol 2005; 45: 450-452.
Workowski K.A., Berman S. Centers for Disease Control and Prevention, Sexually transmitted diseases treatment guidelines 2010. MMWR Recomm Rep 2010; 59RR-12: 56-62.
European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge 2011; IUSTI/WHO 2011; 111.
Ferris M.J., Masztal A., Aldridge K.E., Fortenberry J.D., Fidel P.L.Jr., Martin D.H. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 2004; 4: 5.
Fidel P.L.Jr., Barousse M., Espinosa T. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun 2004; 72: 5: 2939-2946.
Fredricks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005; 353: 1899-1911.
Fredricks D.N., Fiedler T.L., Thomas K.K., Marrazzo J.M. Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol 2007; 45: 10: 3270-3276.
Giraldo P.C., Babula O., Goncealves A.K. Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis. Obstet Gynecol 2007; 109: 5: 1123-1238.
Goldenberg R.L., Culhane J.F., Iams J.D. Epidemiology and causes of preterm birth. Lancet 2008; 371: 9606: 75-84.
Kalra A., Palcu C.T., Sobel J.D., Chaim W., Nagappan V., Wiesenfeld H.C. Bacterial vaginosis: culture- and PCR-based characterizations of a complex polymicrobial disease's pathobiology. Curr Infect Dis Rep 2007; 9: 6: 485-500.
Landers D.V., Wiesenfeld H.C., Heine R.P., Ferris D.G., Martens M., Sobel J.D. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol 2004; 190: 1004-1010.
Leitich H., Bodner-Adler B., Brunbauer M., Kaider A., Egarter C., Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a metaanalysis. Am J Obstet Gynecol 2003; 189: 139-147.
Livengood C.H., Ferris D.G., Wiesenfeld H.C., Sobel J.D., Martens M., Masztal A., Aldridge K.E. Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol 2007; 110: 302-309.
Mastromarino P., Macchia S., Meggiorini L. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect 2009; 15: 67-74.
Nurbhai M., Grimshaw J., Watson M. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev 2007; 4: CD002845.
Nyirjesy P., McIntosh M.J., Steinmetz J.I. The effects of intravaginal clindamycin and metronidazole therapy on vaginal mobiluncus morphotypes in patients with bacterial vaginosis. Sex Transm Dis 2007; 34: 197-202.
Oduyebo O.O., Anorlu R.I., Ogunsola F.T. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database of Syst Rev 2009, Issue 3: CD006055.
Ohmit S.E., Sobel J.D., Schuman P., Masztal A., Aldridge K.E., Schuster M.G., Edwards J.E.Jr. A longitudinal study of mucosal Candida colonization and candidiasis among HIV-seropositive and at-risk HIV-seronegative women. J Infect Dis 2003; 188: 118-127.
Phillips A.J. Treatment of non-albicans Candida vaginitis with amphotericin B vaginal suppositories. Am J Obstet Gynecol 2005; 192: 6: 2009-2012.
Pirotta M.V., Garland S.M. Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics. J Clin Microbiol 2006; 44: 9: 3213-3217.
Pirotta M., Gunn J., Chondros P., Garland S.M. Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial. BMJ 2004; 329: 7465: 548.
Richter S.S., Galask R.P., Messer S.A. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol 2005; 43: 5: 2155-2162.
Schwebke J.R., Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol 2007; 196: 6: 517: 1-6.
Schuster M.G., Edwards J.E.Jr., Sobel J.D., Chaim W., Wiesenfeld H.C. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 2008; 149: 83-90.
Seidman L.S., Skokos C.K. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. Infect Dis Obstet Gynec 2005; 13: 4: 197-206.
Sobel J.D., Chaim W., Nagappan V., Wiesenfeld H.C., Ohmit S.E. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol 2003; 189: 5: 1297-1300.
Sobel J.D., Wiesenfeld H.C., Martens M., Danna P., Hooton T., Rompalo A. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 2004; 351: 9: 876-883.
Torok M.R., Miller W.C., Hobbs M.M. The association between Trichomonas vaginalis infection and level of vaginal lactobacilli, in nonpregnant women. J Infect Dis 2007; 196: 7: 1102-1107.
Verhelst R., Verstraelen H., Claeys G., Verschraegen G., Delanghe J., Van Simaey L., De Ganck C., Temmerman M., Vaneechoutte M. Cloning of 16S rrna genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol 2004; 4: 16.
Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect 2004; 80: 8-11.
Yudin M.H., Landers D.V., Meyn L., Hillier S.L. Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy. Obstet Gynecol 2003; 102: 3: 527-534.